Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVLS.L Regulatory News (VLS)

  • There is currently no data for VLS

Director/PDMR Shareholding

16 Dec 2019 07:00

RNS Number : 8847W
Velocys PLC
16 December 2019
 

News release

Velocys plc

("Velocys" or "the Company")

16 December 2019

 

Grant of Share Options to Directors

Velocys plc (VLS.L), the sustainable fuels technology company announces that it has been notified on 13 December 2019 by Henrik Wareborn, Chief Executive Officer and a director of the Company, and Andrew Morris, Chief Financial Officer and a director of the Company, that they were granted options ("Option Grants") on 13 December 2019 under the Velocys 2012 Share Option Scheme (as amended) over the Company's Ordinary shares of £0.01 each ("Ordinary Shares"). The Option Grants, which have been made under the Rules of the Velocys 2012 Share Option Scheme and follow discussions with major shareholders, were as follows:

 

 

Name of Director

Type of share option

Number of share options granted

 

Exercise price

Vesting/

Exercise

(See notes below)

Total number of share options as % of present issued share capital

 Henrik Wareborn

Commencement Award

Performance Award

Annual Award 2019

2,000,000

2,000,000

6,250,000

£0.10

£0.15

£0.03

 

Note 1

Note 2

Note 3

0.31%

0.31%

0.97%

Andrew Morris

Commencement Award

Performance Award

Annual Award 2019

2,000,000

2,000,000

5,625,000

£0.10

£0.15

£0.03

 

Note 1

Note 2

Note 3

0.31%

0.31%

0.87%

 

Following these notifications:

 

(i) Henrik Wareborn is interested in 1,666,666 Ordinary Shares and Options over 10,250,000 Ordinary Shares of the Company, together representing 1.85% of the present issued share capital of the Company.

 

(ii) Andrew Morris is interested in 433,333 Ordinary Shares and Options over 9,625,000 Ordinary Shares of the Company, together representing 1.56% of the present issued share capital of the Company.

 

The Option Grants are in addition to one-off Special Awards of share options over 16,700,000 Ordinary Shares (representing 2.59% of the present issued share capital) to Velocys' other key staff to compensate for an absence of share awards in recent years, and of share options over 15,250,146 Ordinary Shares (representing 2.37% of the present issued share capital) to Velocys' other key staff in respect of share awards for the 2019 financial year.

 

The above options are subject to terms for Malus and Clawback and may not in any event be exercised later than the day immediately preceding the tenth anniversary of the date of grant.

 

Note 1: Commencement awards vest as to two-thirds on the date of grant and as to the balance on 4 December 2020.

 

Note 2: Performance Awards are only exercisable subject to the weighted average share price of an Ordinary Share being equal to or more than £0.15 measured during specified periods within the performance period which expires on 31 December 2022.

 

Note 3: Annual awards vest as to:

 

(i) 50% on the third anniversary of the date of grant and

(ii) 50% on the third anniversary of the date of grant subject to the weighted average share price of an Ordinary Share being equal to or more than £0.045 during the month preceding the third anniversary of the date of grant.

 

 

- Ends -

 

For further information, please contact:

Velocys

Henrik Wareborn, CEO

Andrew Morris, CFO

 

+44 1865 800821

Numis Securities (Nomad and joint broker)

Stuart Skinner

Tom Ballard

 

+44 20 7260 1000

Canaccord Genuity (Joint broker)

Henry Fitzgerald-O'Connor

James Asensio

+44 20 7523 8000  

Radnor Capital (Investor relations)

Joshua Cryer

Iain Daly

 

+44 20 3897 1830

 

Field Consulting (PR)

Robert Jeffery

 +44 20 7096 7730

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHDMMMZKFZGLZM
Date   Source Headline
10th Nov 20217:01 amRNSSAF OFFTAKE WITH IAG
10th Nov 20217:00 amRNSSAF OFFTAKE WITH SOUTHWEST AIRLINES
28th Oct 20214:40 pmRNSSecond Price Monitoring Extn
28th Oct 20214:35 pmRNSPrice Monitoring Extension
20th Oct 20214:35 pmRNSPrice Monitoring Extension
24th Sep 20217:00 amRNSInvestor Presentation
23rd Sep 20217:00 amRNSHalf-year Report
14th Sep 20217:00 amRNSUS government SAF policy support
1st Sep 20217:00 amRNSGrant of up to £2.4M awarded for Altalto project
31st Aug 20217:00 amRNSVelocys collaboration with Toyo advances
25th Aug 20217:00 amRNSE-fuels project
20th Aug 20214:40 pmRNSSecond Price Monitoring Extn
20th Aug 20214:35 pmRNSPrice Monitoring Extension
18th Aug 20214:41 pmRNSSecond Price Monitoring Extn
18th Aug 20214:35 pmRNSPrice Monitoring Extension
11th Aug 20217:00 amRNSHolding(s) in Company
3rd Aug 20219:00 amRNSApplication for Block Admission
26th Jul 20217:00 amRNSDirectorate Change
5th Jul 202111:55 amRNSBlock listing Interim Review
1st Jul 202110:00 amRNSTotal Voting Rights
30th Jun 20217:00 amRNSVelocys U.S. SAF project update
23rd Jun 20212:38 pmRNSResult of AGM
21st Jun 20217:00 amRNSVelocys technology powers first commercial flight
1st Jun 20217:00 amRNSTotal Voting Rights
27th May 20217:00 amRNSMailing of 2020 annual report and AGM notice
20th May 20211:28 pmRNSInvestor Presentation
18th May 202111:58 amRNSDirector/PDMR Shareholding
17th May 20217:00 amRNSFinal Results
12th May 20214:40 pmRNSSecond Price Monitoring Extn
12th May 20214:35 pmRNSPrice Monitoring Extension
12th Apr 20211:51 pmRNSHolding(s) in Company
30th Mar 20218:14 amRNSVelocys and British Airways extend Altalto option
30th Mar 20217:00 amRNSVelocys and British Airways extend Altalto option
17th Mar 20214:36 pmRNSPrice Monitoring Extension
23rd Feb 20214:36 pmRNSPrice Monitoring Extension
10th Feb 20217:00 amRNSDirector/PDMR Shareholding
8th Feb 20217:00 amRNSToyo and Velocys execute a Collaboration Agreement
1st Feb 202112:17 pmRNSTotal Voting Rights
18th Jan 20217:00 amRNSStrategy/Company/Ops Update
5th Jan 202112:00 pmRNSBlock listing Interim Review
16th Dec 20207:00 amRNSChange of Adviser
15th Dec 20207:00 amRNSResolution of Ventech Trustees Claim
27th Nov 20204:41 pmRNSSecond Price Monitoring Extn
27th Nov 20204:37 pmRNSPrice Monitoring Extension
24th Nov 20204:35 pmRNSPrice Monitoring Extension
12th Nov 20204:41 pmRNSSecond Price Monitoring Extn
12th Nov 20204:36 pmRNSPrice Monitoring Extension
2nd Nov 202011:09 amRNSTotal Voting Rights
17th Sep 20207:00 amRNSHalf-year Report
2nd Sep 20201:59 pmRNSResults of Annual General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.